Bronchodilator combinations for COPD: real hopes or a new Pandora’s box?
N. Roche, P. Chanez
semanticscholar +1 more source
Monitoring COPD patients systemic and bronchial eosinophilic inflammation in a 2-year follow-up: few concerns. [PDF]
Balan D, Manu MK.
europepmc +1 more source
Assessment of ventilation heterogeneity in severe asthma using phase-resolved functional lung magnetic resonance imaging. [PDF]
Foo CT+5 more
europepmc +1 more source
Development of a Scoring System to Predict Suboptimal Peak Inspiratory Flow in Patients With Chronic Obstructive Pulmonary Disease. [PDF]
Kim SH+9 more
europepmc +1 more source
Patient response and remission in respiratory disease: Special focus on severe asthma and chronic obstructive pulmonary disease. [PDF]
Colantuono S+6 more
europepmc +1 more source
Paradigm Shift in the Treatment of Chronic Obstructive Pulmonary Disease Improves Patient Outcomes. [PDF]
Huang YJ+6 more
europepmc +1 more source
Comparison of oscillometry with lung function parameters between patients with stable bronchial asthma with airflow obstruction and chronic obstructive pulmonary disease. [PDF]
De S, Sarda AA.
europepmc +1 more source
The effect of a post-bronchodilator FEV<sub>1</sub>/FVC < 0.7 on COPD diagnosis and treatment: a regression discontinuity design. [PDF]
Moffett AT, Halpern SD, Weissman GE.
europepmc +1 more source
Pharmacogenetic Factors Shaping Treatment Outcomes in Chronic Obstructive Pulmonary Disease. [PDF]
Ntenti C, Misirlis TN, Goulas A.
europepmc +1 more source